<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05617495</url>
  </required_header>
  <id_info>
    <org_study_id>8345</org_study_id>
    <nct_id>NCT05617495</nct_id>
  </id_info>
  <brief_title>Mindfulness-Based fMRI Neurofeedback for Depression</brief_title>
  <acronym>mbNF</acronym>
  <official_title>Mindfulness-Based Real-Time fMRI Neurofeedback for Adolescent Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northeastern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the United States, adolescents experience alarmingly high rates of major depression, and&#xD;
      gold-standard treatments are only effective for approximately half of patients. Rumination&#xD;
      may be a promising treatment target, as it is well-characterized at the neural level and&#xD;
      contributes to depression onset, maintenance, and recurrence as well as predicts treatment&#xD;
      non-response. Accordingly, the proposed research will investigate whether an innovative&#xD;
      mindfulness-based real-time functional magnetic resonance imaging (fMRI) neurofeedback&#xD;
      intervention successfully elicits change in the brain circuit underlying rumination to&#xD;
      improve clinical outcomes among depressed adolescents.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adolescent major depressive disorder (MDD) is common and debilitating. Presently,&#xD;
      gold-standard treatments are only effective for approximately half of patients, underscoring&#xD;
      the need to develop novel interventions, particularly to target core underlying mechanisms&#xD;
      and more effectively treat this recurrent disorder.&#xD;
&#xD;
      Rumination, the tendency to perseverate about depressive symptoms, contributes to MDD onset&#xD;
      and predicts treatment non-response and relapse. At the neural level, rumination is&#xD;
      characterized by elevated functional connectivity within the default mode network (DMN), and&#xD;
      similarly, prior research has consistently demonstrated patterns of DMN hyper-connectivity in&#xD;
      MDD. Interestingly, mindfulness meditation, which trains attentional focus to the present&#xD;
      moment, reduces perseverative thinking, ruminative tendencies, and depression symptoms.&#xD;
      Further, our research and others have shown that adolescents can apply mindfulness practices&#xD;
      to decrease perceived stress, increase sustained attention, and suppress DMN activity.&#xD;
      Although mindfulness has profound mental health benefits, for some, mindfulness alone may not&#xD;
      be sufficient to mitigate ruminative tendencies during a depressive episode. That is, MDD&#xD;
      symptoms, including reduced motivation, inattention, and lack of self-efficacy, may impede a&#xD;
      patient's progress in successfully acquiring and utilizing mindfulness strategies necessary&#xD;
      to change perceptions about one's environment and relationships. To directly address this&#xD;
      challenge, this project will use real-time fMRI neurofeedback to enhance the acquisition and&#xD;
      utilization of mindfulness skills to better target DMN hyper-connectivity, rumination, and&#xD;
      depressive symptoms.&#xD;
&#xD;
      Specifically, a novel, mindfulness-based, real-time neurofeedback (mbNF) paradigm will be&#xD;
      used whereby people observe a visual display of their brain activity and practice mindfulness&#xD;
      to volitionally reduce DMN activation. 90 adolescents (ages 13-18) diagnosed with MDD will&#xD;
      complete a 45-minute mindfulness training outside the scanner. To test target engagement of&#xD;
      reducing DMN hyper-connectivity and optimal dosing, adolescents will then be randomized to&#xD;
      receive either a 15- or a 30-minute mbNF session (n=45/dose group). Clinician-administered&#xD;
      instruments, self-reports, and ecological momentary assessment will be used test whether mbNF&#xD;
      contributes to a greater reduction in clinician assessed depression symptoms (primary&#xD;
      outcome) as well as decreased rumination (secondary outcome) across the post-treatment and&#xD;
      1-month post-treatment. As a whole, mbNF is directly in line with precision medicine&#xD;
      initiatives, and if successful, could revolutionize clinical care for depressed adolescents.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2, 2023</start_date>
  <completion_date type="Anticipated">April 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Within-person Default Mode Network (DMN) Connectivity</measure>
    <time_frame>Immediately Post-mbNF procedure</time_frame>
    <description>DMN change will be assessed via fMRI from pre and post mbNF. We anticipate changes in DMN connectivity following mbNF.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-Report Depression Symptoms</measure>
    <time_frame>Immediately Post-mbNF procedure</time_frame>
    <description>Change in self-report of depression symptoms from baseline to post-mbNF assessed through the Mood and Feelings QuestionnaireSelf-report of depression symptoms through the Mood and Feelings Questionnaire; 33-items with each item ranging from 0-2; Higher scores reflect greater depression symptom severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Report Depression Symptoms</measure>
    <time_frame>1-month</time_frame>
    <description>Change in self-report of depression symptoms from baseline to 1-month post-mbNF assessed through the Mood and Feelings Questionnaire; 33-items with each item ranging from 0-2; Higher scores reflect greater depression symptom severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interviewer-Assessed Depression Symptoms</measure>
    <time_frame>1-month</time_frame>
    <description>Change in depressive symptoms from baseline to 1-month post mbNF assessed via the Children's Depression Rating Scale - Revised, which is a clinician interview of depression symptoms. Scores range from 17 to 119 with higher scores reflecting greater depression symptom severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Reported Rumination</measure>
    <time_frame>Immediately Post-mbNF procedure</time_frame>
    <description>Change in self-report of rumination symptoms from baseline to post-mbNF assessed assessed through the Ruminative Response Scale; 22-items with each item ranging from 1-4; Higher scores reflect greater rumination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Reported Rumination</measure>
    <time_frame>1-month</time_frame>
    <description>Change in self-report of rumination symptoms from baseline to 1-month post-mbNF assessed through the Ruminative Response Scale; 22-items with each item ranging from 1-4; Higher scores reflect greater rumination.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Ecological Momentary Assessment of Depression Symptoms</measure>
    <time_frame>Immediately Post-mbNF procedure</time_frame>
    <description>Change in self-report of depressive symptoms from baseline to post-mbNF assessed through the Patient Health Questionnaire (PHQ)-2 delivered via ecological momentary assessment over a 7-day period; 2-items with each item ranging from 0-100; Higher scores reflect greater depression severity.</description>
  </other_outcome>
  <other_outcome>
    <measure>Ecological Momentary Assessment of Depression Symptoms</measure>
    <time_frame>1-month</time_frame>
    <description>Change in self-report of depressive symptoms from baseline to 1-month post-mbNF assessed through the Patient Health Questionnaire (PHQ)-2 delivered via ecological momentary assessment over a 7-day period; 2-items with each item ranging from 0-100; Higher scores reflect greater depression severity.</description>
  </other_outcome>
  <other_outcome>
    <measure>Ecological Momentary Assessment of Rumination</measure>
    <time_frame>Immediately Post-mbNF procedure</time_frame>
    <description>Change in self-report of rumination (5-items) from baseline to post-mbNF assessed via ecological momentary assessment over a 7-day period; 5-items with each item ranging from 0-100; Higher scores reflect greater rumination.</description>
  </other_outcome>
  <other_outcome>
    <measure>Ecological Momentary Assessment of Rumination</measure>
    <time_frame>1-month</time_frame>
    <description>Change in self-report of rumination (5-items) from baseline to 1-month post-mbNF assessed via ecological momentary assessment over a 7-day period; 5-items with each item ranging from 0-100; Higher scores reflect greater rumination.</description>
  </other_outcome>
  <other_outcome>
    <measure>Ecological Momentary Assessment of Mindfulness</measure>
    <time_frame>Immediately Post-mbNF procedure</time_frame>
    <description>Change in self-report of mindfulness (3-items) from baseline to post-mbNF assessed via ecological momentary assessment over a 7-day period; 3-items with each item ranging from 0-100; Higher scores reflect greater mindfulness.</description>
  </other_outcome>
  <other_outcome>
    <measure>Ecological Momentary Assessment of Mindfulness</measure>
    <time_frame>1-month</time_frame>
    <description>Change in self-report of mindfulness (3-items) from baseline to 1-month post-mbNF assessed via ecological momentary assessment over a 7-day period; 3-items with each item ranging from 0-100; Higher scores reflect greater mindfulness.</description>
  </other_outcome>
  <other_outcome>
    <measure>Default Mode Network (DMN) and Frontoparietal Control Network (FPCN) Anticorrelation</measure>
    <time_frame>Immediately Post-mbNF procedure</time_frame>
    <description>Anticorrelation between DMN and FPCN will be assessed via fMRI from pre and post mbNF. We anticipate changes in DMN-FPCN anticorrelation.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Depression in Adolescence</condition>
  <condition>Rumination</condition>
  <arm_group>
    <arm_group_label>15-Minute mbNF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receiving 15-minute session of mbNF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30-Minute mbNF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receiving 30-minute session of mbNF</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fMRI Neurofeedback</intervention_name>
    <description>Participants will receive mindfulness-based fMRI neurofeedback targeting the default mode network and central executive network.</description>
    <arm_group_label>15-Minute mbNF</arm_group_label>
    <arm_group_label>30-Minute mbNF</arm_group_label>
    <other_name>Mindfulness-based Real-time fMRI Neurofeedback</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages 13-18 years-old&#xD;
&#xD;
          -  Written informed assent/consent; parental/guardian permission for 13-17 year-olds or&#xD;
             consent for 18 year-olds&#xD;
&#xD;
          -  Tanner puberty stage â‰¥3&#xD;
&#xD;
          -  Current diagnostic criteria for MDD&#xD;
&#xD;
          -  English fluency&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lifetime history of primary psychotic disorders, bipolar disorder, oppositional&#xD;
             defiant disorder, conduct disorder, developmental disorder (e.g., autism),&#xD;
             post-traumatic stress disorder, or eating disorders&#xD;
&#xD;
          -  Substance use disorder, moderate or severe in past 6 months&#xD;
&#xD;
          -  Active suicidal ideation with a specific plan&#xD;
&#xD;
          -  History of seizure disorder&#xD;
&#xD;
          -  Medical or neurological illness (e.g., head injury, loss of consciousness &gt;5 minutes)&#xD;
&#xD;
          -  MRI contraindications&#xD;
&#xD;
          -  Current psychotropic medication use other than antidepressant medication&#xD;
&#xD;
          -  Intelligence quotient (IQ) &lt;80.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Randy P Auerbach, PhD</last_name>
    <phone>646-774-5745</phone>
    <email>rpa2009@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mia Kyler, BA</last_name>
    <phone>646-774-5318</phone>
    <email>mia.kyler@nyspi.columbia.edu</email>
  </overall_contact_backup>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>November 1, 2022</study_first_submitted>
  <study_first_submitted_qc>November 14, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2022</study_first_posted>
  <last_update_submitted>January 31, 2023</last_update_submitted>
  <last_update_submitted_qc>January 31, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Randy P. Auerbach, Ph.D., ABPP</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Real-time fMRI Neurofeedback</keyword>
  <keyword>Mindfulness</keyword>
  <keyword>Rumination</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rumination Syndrome</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We will upload de-identified data to the NIMH NDA.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

